Stock Comparison

CTMX vs AAPL

Side-by-side fundamentals, quality, value, and price momentum analysis.

Tickers 2 / 10100+ Metrics

Selected Stocks

Add up to 10 tickers. Use presets or search to get started.

2 / 10
Quick presets:

Metrics Comparison

Best values highlighted in green, worst in red. Scroll horizontally to see all tickers.

MetricCTMXCytomX Therapeutics, Inc.AAPLApple Inc.
Market Cap$692.99M$3.84T
Current Price$4.09$261.05
P/E Ratio10.7634.99
Revenue Growth 1Y36.4%6.4%
Net Margin23.1%26.9%
ROE26.1%171.4%
ROIC70.6%
Debt/Equity1.34
FCF Yield2.6%
Dividend Yield0.4%
Loading chart...

CTMX vs AAPL: Key Questions Answered

Which is the cheapest stock: CTMX or AAPL?

Based on P/E ratio, CytomX Therapeutics, Inc. (CTMX) is the cheapest at 10.8x earnings. Apple Inc. (AAPL) is the most expensive at 35.0x. A lower P/E can indicate better value, but always consider growth rates too.

Which stock is growing the fastest: CTMX or AAPL?

CytomX Therapeutics, Inc. (CTMX) is growing the fastest with 36.4% revenue growth. Apple Inc. has the slowest growth at 6.4%. Higher growth often justifies higher valuations.

Which has the best profit margins: CTMX or AAPL?

Apple Inc. (AAPL) has the strongest profitability with a 26.9% net margin. CytomX Therapeutics, Inc. has the lowest at 23.1%. Higher margins indicate pricing power and efficiency.

Which is the largest company: CTMX or AAPL?

Apple Inc. (AAPL) is the largest company with a market cap of $3.84T. CytomX Therapeutics, Inc. is the smallest at $0.7B. Larger companies tend to be more stable but may have less growth potential.

Which stock has the best return on equity: CTMX or AAPL?

Apple Inc. (AAPL) generates the best returns on shareholder equity with an ROE of 1.7%. CytomX Therapeutics, Inc. has the lowest at 26.1%. Higher ROE indicates efficient use of capital.